MBE
ALNY icon

Michael B. Elefante’s Alnylam Pharmaceuticals ALNY Stock Holding History

Michael B. Elefante’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-7,840
Closed -$612K – 110
2014
Q3 		$612K Hold
7,840
– – 0.26% 58
2014
Q2 		$495K Buy
7,840
+150
+2% +$8.92K 0.21% 62
2014
Q1 		$517K Sell
7,690
-7,685
-50% -$595K 0.22% 60
2013
Q4 		$989K Sell
15,375
-1,355
-8% -$80.8K 0.46% 48
2013
Q3 		$1.07M Hold
16,730
– – 0.54% 44
2013
Q2 		$518K Buy
+16,730
New +$445K 0.28% 53

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Alpha Wave Global
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return

Michael B. Elefante's ALNY Position: Q4 2014 in Review

Michael B. Elefante sold out of Alnylam Pharmaceuticals (ALNY) in Q4 2014, closing a stake of 7,840 shares — an estimated $612K sold.

Michael B. Elefante first reported a position in ALNY in Q2 2013 and held it in 6 quarters. The position peaked at $1.07M in Q3 2013. 216 funds tracked by Wall St. Rank hold ALNY as of Q4 2014.

  • Michael B. Elefante reported no remaining Alnylam Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Michael B. Elefante sold 7,840 Alnylam Pharmaceuticals shares in Q4 2014, an estimated $612K.
  • Michael B. Elefante first reported a position in Alnylam Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • Michael B. Elefante's Alnylam Pharmaceuticals position peaked at $1.07M in Q3 2013.
  • 216 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2014.

Based on Michael B. Elefante's 13F filing for Q4 2014, filed 13 Feb 2015.